Abliva AB (publ) (STO:ABLI)
Sweden
· Delayed Price · Currency is SEK 0.450
0.00 (0.00%)
Feb 21, 2025, 5:24 PM CET
Abliva AB Revenue
In the year 2024, Abliva AB had annual revenue of 497.00K SEK with 262.77% growth. Abliva AB had revenue of 207.00K in the quarter ending December 31, 2024, with 51.09% growth.
Revenue
497.00K
Revenue Growth
+262.77%
P/S Ratio
n/a
Revenue / Employee
82.83K
Employees
8
Market Cap
725.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 497.00K | 360.00K | 262.77% |
| Dec 31, 2023 | 137.00K | 106.00K | 341.94% |
| Dec 31, 2022 | 31.00K | -120.00K | -79.47% |
| Dec 31, 2021 | 151.00K | -1.57M | -91.20% |
| Dec 31, 2020 | 1.72M | -1.92M | -52.78% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.03B |
| Getinge AB | 34.76B |
| Sectra AB | 3.14B |
| Camurus AB | 1.87B |
| Medicover AB | 23.97B |
| Vitrolife AB | 3.61B |
| Elekta AB | 17.88B |
| Vimian Group AB | 4.29B |